. . . . . . . . "Ketamine remains an off-label treatment for treatment-resistant depression with factors that limit widespread use including its dissociative effects and abuse potential." . . . . . . "Adults" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "UuTMVXFvkxk5Ew/EaWAmH7RVBKDagZ+lFovh7LYZrGW7jsWkBCcxvCVNL8aHdKi+5zPloB7Y4EqRNMXJQVi+gzU9+jElyqop4gcHr+i/GV4eEIINs6UNiCD6GkN8lWl3yDCvJjUG6DXeT9m7DmSwGyfDPkkZxWILEzk6WJT7rQ0=" . . "2021-08-10T16:16:29.784+02:00"^^ . . . . . . .